Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis c Genotype 1”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00863239
What this trial is testing

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT01628692
What this trial is testing

Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 230
Testing effectiveness (Phase 2)Study completedNCT02350569
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 17
Testing effectiveness (Phase 2)Study completedNCT02219685
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00996476
What this trial is testing

Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 92
Testing effectiveness (Phase 2)Study completedNCT00720434
What this trial is testing

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C
Pfizer 35
Not applicableStudy completedNCT02629172
What this trial is testing

Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

Who this might be right for
Chronic Hepatitis C Virus
AbbVie 3,043
Not applicableStudy completedNCT01750216
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 196
Testing effectiveness (Phase 2)Study completedNCT02378935
What this trial is testing

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 205
Early research (Phase 1)Study completedNCT01185860
What this trial is testing

Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 59
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Early research (Phase 1)Study completedNCT00529321
What this trial is testing

Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C, Chronic
Transgene 42
Testing effectiveness (Phase 2)Study completedNCT00664625
What this trial is testing

A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 24
Post-approval studies (Phase 4)UnknownNCT02950870
What this trial is testing

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Who this might be right for
Chronic Hepatitis, C Virus
University of Modena and Reggio Emilia 75
Testing effectiveness (Phase 2)Study completedNCT02765490
What this trial is testing

Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 365
Large-scale testing (Phase 3)Study completedNCT01399619
What this trial is testing

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 310
Not applicableStudy completedNCT01641094
What this trial is testing

Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 20
Testing effectiveness (Phase 2)Study completedNCT03458481
What this trial is testing

Phase 2 Study of Yimitasvir Phosphate Capsules

Who this might be right for
Chronic HCV Infection
Sunshine Lake Pharma Co., Ltd. 129
Early research (Phase 1)Study completedNCT01081158
What this trial is testing

Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 41
Large-scale testing (Phase 3)Study completedNCT00758043
What this trial is testing

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 540
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation